CLOs on the Move


 
Founded in 2004 by Rob Landerholm, MD FACS and Peter Billing, MD FACS, Eviva set out to provide excellence in patient care with a focus on leading edge bariatric (weight loss) surgery. Prominently known as industry leaders in bariatrics, Eviva has also maintained steady growth in a variety of services. The objective of our founding surgeons has come to fruition and we are pleased to have acquired a growing team of physicians and specialized care providers who share the same goals. We are leaders in performing advanced laparoscopic surgical procedures as well as a variety of specialty and preventative care services. ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.evivamd.com
  • 21911 76th Avenue W Suite 106
    Edmonds, WA USA 98026
  • Phone: 425.778.2220

Executives

Name Title Contact Details

Similar Companies

MedaPhase

MedaPhase is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioVentrix

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA.

Equipment Collaborative

Equipment Collaborative is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Insulet

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnpod technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 100,000 users across the globe rely on Insulet`s Omnipod Insulin Management System to bring simplicity and freedom to their lives. For more information, please visit: www.insulet.com, www.myomnipod.com and https://www.omnipodeurope.com.* *Starting July 1, 2018, Insulet will assume direct distribution of its Omnipod Insulin Management System in Europe, including sales, marketing, training and customer support activities. This will allow Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long term, as it already does in the United States and Canada.

New England Home Therapies

New England Home Therapies is a Southborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.